CAR T-cell therapy in refractory large B-cell lymphoma

被引：11
|
作者：
Stirrups, Robert
机构：
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 01期
关键词：
D O I：
10.1016/S1470-2045(17)30928-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E19 / E19
页数：1
相关论文
共 50 条
  • [41] Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
    Crochet, Gilles
    Iacoboni, Gloria
    Couturier, Audrey
    Bachy, Emmanuel
    Iraola-Truchuelo, Josu
    Gastinne, Thomas
    Cartron, Guillaume
    Fradon, Tom
    Lesne, Bastien
    Kwon, Mi
    Gounot, Romain
    Martinez-Cibrian, Nuria
    Castilla-Llorente, Cristina
    Abrisqueta, Pau
    Guerreiro, Manuel
    Sarkozy, Clementine
    Aspa-Cilleruelo, Jose Maria
    Camus, Vincent
    Guidez, Stephanie
    Chauchet, Adrien
    Deconinck, Eric
    Bouabdallah, Krimo
    Bosch, Francesc
    Barba, Pere
    Morschhauser, Franck
    Houot, Roch
    BLOOD, 2024, 144 (03) : 334 - 338
  • [42] Transdifferentiation of diffuse large B-cell lymphoma to a poorly differentiated neoplasm following CAR T-cell therapy
    Padmanabha, Nandan
    Weinstock, Matthew J.
    Xu, Sean
    Lepe, Marcos
    Garrett, Leslie A.
    Kappes, Ulrike P.
    Michaels, Phillip D.
    JOURNAL OF HEMATOPATHOLOGY, 2024, 17 (03) : 149 - 153
  • [43] Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy
    Yagi, Yu
    Kanemasa, Yusuke
    Sasaki, Yuki
    Goto, Sotaro
    Yamamura, Yasuhiko
    Masuda, Yusuke
    Fujita, Kumiko
    Ishimine, Kento
    Hayashi, Yudai
    Mino, Mano
    Ohigashi, An
    Morita, Yuka
    Tamura, Taichi
    Nakamura, Shohei
    Okuya, Toshihiro
    Matsuda, Shinichiro
    Shimizuguchi, Takuya
    Shingai, Naoki
    Toya, Takashi
    Shimizu, Hiroaki
    Najima, Yuho
    Kobayashi, Takeshi
    Haraguchi, Kyoko
    Doki, Noriko
    Okuyama, Yoshiki
    Shimoyama, Tatsu
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (02) : 107 - 118
  • [44] CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview
    Mohty, Mohamad
    Dulery, Remy
    Gauthier, Jordan
    Malard, Florent
    Brissot, Eolia
    Aljurf, Mahmoud
    Bazarbachi, Ali
    Chabanon, Christian
    Kharfan-Dabaja, Mohamed A.
    Savani, Bipin N.
    Huang, He
    Kenderian, Saad S.
    Perales, Miguel-Angel
    Yakoub-Agha, Ibrahim
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2020, 55 (08) : 1525 - 1532
  • [45] CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview
    Mohamad Mohty
    Remy Dulery
    Jordan Gauthier
    Florent Malard
    Eolia Brissot
    Mahmoud Aljurf
    Ali Bazarbachi
    Christian Chabanon
    Mohamed A. Kharfan-Dabaja
    Bipin N. Savani
    He Huang
    Saad S. Kenderian
    Miguel-Angel Perales
    Ibrahim Yakoub-Agha
    Arnon Nagler
    Bone Marrow Transplantation, 2020, 55 : 1525 - 1532
  • [46] Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Andersson, Per-Ola
    Sonnevi, Kristina
    Ljungqvist, Maria
    Sander, Birgitta
    Jerkeman, Mats
    Smedby, Karin E.
    LEUKEMIA & LYMPHOMA, 2024, 65 (04) : 534 - 537
  • [47] Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study
    Roche, Pauline
    Brisou, Gabriel
    Furst, Sabine
    Noel, Robin
    De Oca, Catalina Montes
    Collignon, Aude
    Inchiappa, Luca
    De Colella, Jean Marc Schiano
    Rossi, Isabelle Brenot
    Reichert, Thibaut
    Thevenet, Sophie
    Mfarrej, Bechara
    Calmels, Boris
    Blaise, Didier
    Chabannon, Christian
    Devillier, Raynier
    BLOOD, 2022, 140 : 7740 - 7741
  • [48] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients With Relapsed or Refractory Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 15 - 17
  • [49] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma
    Sano, Dahlia
    Nastoupil, Loretta J.
    Fowler, Nathan H.
    Fayad, Luis
    Hagemeister, F. B.
    Lee, Hun Ju
    Samaniego, Felipe
    Wang, Michael
    Rodriguez, Maria Alma
    Iyer, Swaminathan P.
    Parmar, Simrit
    Steiner, Raphael
    Nair, Ranjit
    Adkins, Sherry
    Arafat, Sara
    Rao, Ahalya
    Vallejo, Liliana
    Hawkins, Misha
    Chen, Yiming
    Westin, Jason R.
    Neelapu, Sattva S.
    BLOOD, 2018, 132
  • [50] Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
    Chow, Victor A.
    Shadman, Mazyar
    Gopal, Ajay K.
    BLOOD, 2018, 132 (08) : 777 - 781
12345